CDKN2A and cancer: ANRIL is a large antisense non-coding RNA gene (126-kb region, consisting of 19–21 exons) with the first exon located in the promoter region of CDKN2A, regulating cancer progression through epigenetic silencing of other genes in this cluster (15).